rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2006-3-3
|
pubmed:abstractText |
The aim of the study was to investigate the influence of methylenetetrahydrofolate reductase (MTHFR) gene expression levels and MTHFR polymorphism C677T on the outcome of patients with colorectal cancer (CRC). Furthermore, we wanted to evaluate the interaction between MTHFR and thymidylate synthase (TS) and folylpolyglutamate synthase (FPGS) and to investigate the impact of folate concentration on patients with CRC with different MTHFR genotypes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1533-0028
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
344-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16512993-Adult,
pubmed-meshheading:16512993-Aged,
pubmed-meshheading:16512993-Aged, 80 and over,
pubmed-meshheading:16512993-Carcinoma,
pubmed-meshheading:16512993-Colorectal Neoplasms,
pubmed-meshheading:16512993-Female,
pubmed-meshheading:16512993-Folic Acid,
pubmed-meshheading:16512993-Gene Expression,
pubmed-meshheading:16512993-Humans,
pubmed-meshheading:16512993-Intestinal Mucosa,
pubmed-meshheading:16512993-Male,
pubmed-meshheading:16512993-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:16512993-Middle Aged,
pubmed-meshheading:16512993-RNA, Messenger,
pubmed-meshheading:16512993-Survival Rate
|
pubmed:year |
2006
|
pubmed:articleTitle |
Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer.
|
pubmed:affiliation |
Department of General Surgery, Sahlgrenska University Hospital/ostra, Goteborg, Sweden. elisabeth.odin@dep-surg.gu.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|